Ribavirin treatment chronic hepatitis oral ribavirin therapy chronic hepatitis infection pilot study patients Patients men women mean age years biopsy-proven chronic non-A non-B hepatitis positive antibodies virus Treatment oral ribavirin mg day divided doses weeks median serum alanine aminotransferase concentration patients enrollment mu kat/l mu weeks treatment weeks end treatment median serum alanine aminotransferase concentration different treatment Side-effects mild reversible cessation therapy ribavirin first drug effective oral treatment chronic hepatitis controlled trials combination interferon alpha 